Hearing Vistagen Therapeutics Upgraded From A Hold To A Buy At Jefferies; Price Target $15
Hearing Vistagen Therapeutics Upgraded From A Hold To A Buy At Jefferies; Price Target $15
聽說 Vistagen Therapeutics 在傑富瑞集團從持倉升級爲買入；目標股價爲15美元
Hearing Vistagen Therapeutics Upgraded From A Hold To A Buy At Jefferies; Price Target $15
聽說 Vistagen Therapeutics 在傑富瑞集團從持倉升級爲買入；目標股價爲15美元
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。